AMLX
Price
$13.42
Change
+$0.13 (+0.98%)
Updated
Oct 3 closing price
Capitalization
1.43B
31 days until earnings call
QNTM
Price
$18.45
Change
+$0.35 (+1.93%)
Updated
Oct 3 closing price
Capitalization
70.39M
Interact to see
Advertisement

AMLX vs QNTM

Header iconAMLX vs QNTM Comparison
Open Charts AMLX vs QNTMBanner chart's image
Amylyx Pharmaceuticals
Price$13.42
Change+$0.13 (+0.98%)
Volume$1.2M
Capitalization1.43B
Quantum Biopharma
Price$18.45
Change+$0.35 (+1.93%)
Volume$182.72K
Capitalization70.39M
AMLX vs QNTM Comparison Chart in %
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. QNTM commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and QNTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (AMLX: $13.42 vs. QNTM: $18.45)
Brand notoriety: AMLX and QNTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 72% vs. QNTM: 118%
Market capitalization -- AMLX: $1.43B vs. QNTM: $70.39M
AMLX [@Biotechnology] is valued at $1.43B. QNTM’s [@Biotechnology] market capitalization is $70.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileQNTM’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • QNTM’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than QNTM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 2 TA indicator(s) are bullish while QNTM’s TA Score has 4 bullish TA indicator(s).

  • AMLX’s TA Score: 2 bullish, 4 bearish.
  • QNTM’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, QNTM is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Biotechnology) experienced а -7.58% price change this week, while QNTM (@Biotechnology) price change was +13.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($1.43B) has a higher market cap than QNTM($70.4M). QNTM YTD gains are higher at: 401.359 vs. AMLX (255.026). QNTM has higher annual earnings (EBITDA): -26.86M vs. AMLX (-196.3M). AMLX has more cash in the bank: 181M vs. QNTM (1.53M). QNTM has less debt than AMLX: QNTM (2.27M) vs AMLX (5.96M). QNTM has higher revenues than AMLX: QNTM (0) vs AMLX (-249K).
AMLXQNTMAMLX / QNTM
Capitalization1.43B70.4M2,033%
EBITDA-196.3M-26.86M731%
Gain YTD255.026401.35964%
P/E Ratio2.69N/A-
Revenue-249K0-
Total Cash181M1.53M11,846%
Total Debt5.96M2.27M263%
FUNDAMENTALS RATINGS
QNTM: Fundamental Ratings
QNTM
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXQNTM
RSI
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DRGVX50.450.26
+0.52%
BNY Mellon Dynamic Value Fund I
RGCEX17.340.05
+0.29%
Columbia Select Global Equity C
VMVFX17.140.05
+0.29%
Vanguard Global Minimum Volatility Inv
JHARX10.560.01
+0.09%
JHancock Multi-Asset Absolute Return R2
FCAUX14.14N/A
N/A
Fidelity Advisor Climate Action I

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+0.98%
XOMAO - AMLX
68%
Closely correlated
+0.77%
XOMAP - AMLX
51%
Loosely correlated
+1.23%
RGNX - AMLX
46%
Loosely correlated
-1.42%
OCUL - AMLX
45%
Loosely correlated
+3.16%
JAZZ - AMLX
43%
Loosely correlated
+1.65%
More

QNTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNTM has been loosely correlated with HYPD. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if QNTM jumps, then HYPD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNTM
1D Price
Change %
QNTM100%
+1.93%
HYPD - QNTM
34%
Loosely correlated
-6.42%
ATHE - QNTM
27%
Poorly correlated
+1.43%
CPIX - QNTM
26%
Poorly correlated
-3.40%
AMLX - QNTM
25%
Poorly correlated
+0.98%
EBS - QNTM
24%
Poorly correlated
-0.44%
More